Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction

Virchows Archiv

Volumn 430, Issue 4, 1997, Pages 327-332

  Tada, Toyohiro ^a   Okada, Hidechika ^a   Okada, Noriko ^a   Tateyama, Hisashi ^a   Suzuki, Harumi ^b   Takahashi, Youhei ^c   Eimoto, Tadaaki ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b AICHI PREFECTURAL UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

CD59; Complement; Homologous restriction factor of complement; Membrane attack complex; Myocardial infarction

Indexed keywords

ANTIBODY; CD59 ANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3D; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOPSY; CLINICAL ARTICLE; FEMALE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; TISSUE FIXATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD59; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; TIME FACTORS;

EID: 0030980174     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01092756     Document Type: Article

References (42)

1. Agnello V, Carr RI, Koffler D, Kunnkel HG (1969) Gell diffusion reactions of Clq with aggregated g-globulin, DNA, and various anionic substances (abstract). Fed Proc 28:696
2. Asch AS, Kinoshita T, Jaffe EA, Nussenzweig V (1986) Decay accelerating factor (DAF) is present on cultured human umbilical vein endothelial cells. J Exp Med 163:221-226
3. Boutet M, Huttner I, Rona G (1976) Permeability alteration of sarcolemmal membrane in cathecholamine-induced cardiac muscle cell injury: in vivo studies with fine structural diffusion tracer horseradish peroxidase. Lab Invest 34:482-488
4. Davies A, Simmons DL, Hale G, Harrison RA, Tighe H, Lachmann PJ, Waldmann H (1989) CD59, a Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170:637-654
5. Frank MM, Fries LF (1991) The role of complement in inflammation and phagocytosis. Immunol Today 12:322-326
6. Hill JH, Ward PA (1971) The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med 133: 885-900
7. Hsu S-M, Raine L, Fanger H (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580
8. Hughes TR, Piddlesden SJ, Williams JD, Harrison RA, Morgan BP (1992) Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem J 284: 169-176
9. Hugo F, Hamdoch T, Mathey D, Schafer H, Bhakdi S (1990) Quantative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium. Clin Exp Immunol 81:132-136
10. Kent SP (1966) Intracellular plasma protein: a manifestation of cell injury in myocardial ischemia. Nature 210:1279-1281
11. Kent SP (1967) Diffusion of plasma proteins into cells: a manifestation of cell injury in human myocardial ischemia. Am J Pathol 50:623-637
12. Kovacsovics T, Tschopp J, Kress A, Isliker H (1985) Antibody-independent activation of Cl, the first component of complement, by cardiolipin. J Immunol 135:2695-2700
13. Lachmann PJ (1991) The control of homologous lysis. Immunol Today 12:312-315
14. Maroko PR, Carpenter CB, Chiariello M, Fishbein MC, Radvany P, Knostman JD, Hale SL (1978) Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest 61:661-670
15. Mathey D, Schofer J, Schäfer HJ, Hamdoch T, Joachim HC, Ritgen A, Hugo F, Bhakdi S (1994) Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. Eur Heart J 15:418-423
16. McManus LM, Kolb WP, Crawford MH, O'Rourke RA, Grover FL, Pinckard RN (1983) Complement localization in ischemic baboon myocardium. Lab Invest 48:436-447
17. Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H (1990) Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71:1-9
18. Nicholson-Weller A (1992) Decay accelerating factor (CD55). In: Parker CM (ed) Membrane defenses against attack by complement and perfolins. Springer, Berlin Heidelberg New York, pp 8-30
19. Nose M, Katoh M, Okada N, Kyougoku M, Okada H (1990) Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology 70:145-149
20. Okada N, Harada R, Fujita T, Okada H (1989) Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement. J Immunol 143:2262-2266
21. Okada N, Harada R, Fujita T, Okada H (1989) A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol 1:205-208
22. Peitsch MC, Tschopp J, Kress A, Isliker H (1988) Antibody-independent activation of the complement system by mitochondria is mediated by cardiolipin. Biochem J 249:495-500
23. Pinckard RN, O'Rourke RA, Crawford MH, Grover FS, McManus LM, Ghidoni JJ, Storrs SB, Olson MS (1980) Complement localization and mediation of ischemic injury in baboon myocardium. J Clin Invest 66:1050-1056
24. Reid KBM (1988) The complement system. In: Hames BD, Glover DM (eds) Molecular immunology. IRL Press, Oxford, pp 189-241
25. Reimer KA, Richard VJ, Murry CE, Ideker RE (1991) Myocardial ischemia and infarction: Anatomic and biochemical substrates for ischemic cell death and ventricular arrhythmias. In: Virmani R, Atkinson JB, Fenoglio JJ (eds) Cardiovascular pathology. W. B. Saunders Company, Philadelphia, pp 61-85
26. Rooney IA, Davies A, Griffiths D, Williams JD, Davies M, Meri S, Lachmann PJ, Morgan BP (1991) The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells. Clin Exp Immunol 83:251-256
27. Rossen RD, Swain JL, Michael LH, Weakley S, Giannini E, Entman ML (1985) Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury. Circ Res 57:119-130
28. Rossen RD, Michael LH, Kagiyama A, Savage HE, Hanson G, Reisberg MA, Moake JN, Kim SH, Self D, Weakley S, Giannin E, Entman ML (1988) Mechanism of complement activation after coronary artery occlusion: Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human Clq in vivo. Circ Res 62:572-584
29. Rus HG, Niculescu F, Vlaicu R (1987) Presence of C5b-9 complement complex and S-protein in human myocardial areas with necrosis and sclerosis. Immunol Lett 16:15-20
30. Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y (1986) The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 125:431-435
31. Schäfer H, Mathey D, Hugo F, Bhakdi S (1986) Deposition of the terminal C5b-9 complement in infarcted areas of human myocardium. J Immunol 15:1945-1949
32. Schonermark S, Rauterberg EW, Shin ML, Loke S, Roelcke D, Hansch GM (1986) Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor. J Immunol 136: 1772-1776
33. Seifert PS, Hansson GK (1989) Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. J Clin Invest 84:597-604
34. Seya T, Turner JR, Atkinson JP (1986) Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med 163:837-855
35. Sugita Y, Nakano Y, Tomita M (1988) Isolation from human erythrocytes of a new transmembrane protein which inhibits the formation of complement transmembrane channels. J Biochem 104:633-637
36. Tada T, Okada H, Okada N, Tateyama H, Eimoto T (1993) Expression of 20KD homologous restriction factor of complement on myocardial cells. An immunohistochemical study using acetone-fixed and paraffin-embedded tissues. J Histochem Cytochem 41:119-122
37. Väkevä AV, Laurila P, Meri S (1992) Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab Invest 67:608-616
38. Väkevä A, Laurila P, Meri S (1993) Regulation of complement membrane attack complex formation in myocardial infarction. Am J Pathol 143:65-75
39. Väkevä A, Morgan BP, Tikkanen I, Helin K, Laurila P, Meri S (1994) Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am J Pathol 144:1357-1368
40. Yamashina M, Takami T, Kanemura T, Orii T, Ojima A (1989) Immunohistochemical demonstration of complement components in formalin-fixed and paraffin-embedded renal tissues. Lab Invest 60:311-316
41. Yasuda M, Takeuchi K, Hiruma M, Iida H, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H, Kanayama Y, Takeda T, Kolb WP, Tamerius JD (1990) The complement system in ischemic heart disease. Circulation 81:156-163
42. Zimmermann A, Gerber H, Nussenzweig V, Isliker H (1990) Decay accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction. Virchows Arch [A] 417:299-304